Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2012

Apr 20, 2012

33819_dirs_2012-04-20_7f1d84a2-e152-49af-b587-15c31c44b35e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-04-18

Reporting Person: BJERKHOLT ERIC (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-18 Common Stock A 9000 $0.00 Acquired 12000 Direct

Footnotes

F1: In accordance with Board action taken, this is an equity grant of 9,000 restricted units, vesting 100% on March 1, 2013, as compensation for Board service.

F2: Includes anniversary equity grants of 10,000 restricted stock units, in the aggregate, each vesting 100% on March 1, 2013.